- MUXMcEwen Mining$1.3BReported
MUXQ4 2024
McEwen Mining
View full reportEPS
Estimated
-$0.05
Actual
-$0.16220.0%
Revenue
Estimated
$38.6M
Actual
$166.2M330.6%
- AURAAura Biosciences$775MReported
AURAQ4 2024
Aura Biosciences
View full reportEPS
Estimated
-$0.43
Actual
-$0.5220.9%
Revenue
Estimated
$0.00
Actual
$0.00
- TOIOncology Institute$471MReported
TOIQ4 2024
Oncology Institute
View full reportEPS
Estimated
-$0.07
Actual
-$0.14100.0%
Revenue
Estimated
$109.2M
Actual
$100.0M8.4%
- SGMTSagimet Biosciences$449MReported
SGMTQ4 2024
Sagimet Biosciences
View full reportEPS
Estimated
-$0.63
Actual
-$0.5020.6%
Revenue
Estimated
—
Actual
$0.00
- OKLOOklo$11.8BReported
OKLOQ4 2024
Oklo
View full reportEPS
Estimated
-$0.07
Actual
-$0.0928.6%
Revenue
Estimated
—
Actual
$0.00
- CNTACentessa$6.2BReported
CNTAQ4 2024
Centessa
View full reportEPS
Estimated
-$0.35
Actual
-$0.5865.7%
Revenue
Estimated
$0.00
Actual
$0.00
- KBHKB Home$3.1BReported
KBHQ1 2025
KB Home
View full reportEPS
Estimated
$1.58
Actual
$1.495.7%
Revenue
Estimated
$1.5B
Actual
$1.4B9.8%
- EPACEnerpac$1.7BReported
EPACQ2 2025
Enerpac
View full reportEPS
Estimated
$0.38
Actual
$0.380.9%
Revenue
Estimated
$138.9M
Actual
$145.5M4.8%
- LYRALyra$1.2MReported
LYRAQ4 2024
Lyra
View full reportEPS
Estimated
-$0.13
Actual
-$1.431000.0%
Revenue
Estimated
$204.8K
Actual
$1.5K99.3%
- MKCMcCormick$12.6BReported
MKCQ1 2025
McCormick
View full reportEPS
Estimated
$0.68
Actual
$0.6011.5%
Revenue
Estimated
$1.7B
Actual
$1.6B7.7%
- CNMCore & Main$9.3BReported
CNMQ4 2024
Core & Main
View full reportEPS
Estimated
$0.36
Actual
$0.339.3%
Revenue
Estimated
$1.7B
Actual
$1.7B0.0%
- LUNRIntuitive Machines$7.3BReported
LUNRQ4 2024
Intuitive Machines
View full reportEPS
Estimated
-$0.06
Actual
-$0.16166.7%
Revenue
Estimated
$54.8M
Actual
$54.7M0.1%
- HDLSuper Hi$6.3BReported
HDLQ4 2024
Super Hi
View full reportEPS
Estimated
$0.17
Actual
-$0.02111.8%
Revenue
Estimated
—
Actual
$778.3M
- ATATAtour$3.9BReported
ATATQ4 2024
Atour
View full reportEPS
Estimated
$0.27
Actual
$0.3320.8%
Revenue
Estimated
$280.6M
Actual
$993.0M253.9%
- RUMRumble$3.2BReported
RUMQ4 2024
Rumble
View full reportEPS
Estimated
-$0.13
Actual
-$0.1023.1%
Revenue
Estimated
$30.4M
Actual
$30.2M0.7%
- KALVKalVista$1.4BReported
KALVQ3 2025
KalVista
View full reportEPS
Estimated
-$0.95
Actual
-$0.923.2%
Revenue
Estimated
—
Actual
$0.00
- CSIQCanadian Solar$1.4BReported
CSIQQ4 2024
Canadian Solar
View full reportEPS
Estimated
-$0.18
Actual
-$1.47733.6%
Revenue
Estimated
$1.6B
Actual
$7.6B363.3%
- TRMLTourmaline Bio$601MReported
TRMLQ4 2024
Tourmaline Bio
View full reportEPS
Estimated
-$0.90
Actual
-$0.864.4%
Revenue
Estimated
—
Actual
$0.00
- SMTISanara MedTech$218MReported
SMTIQ4 2024
Sanara MedTech
View full reportEPS
Estimated
-$0.29
Actual
-$0.1837.3%
Revenue
Estimated
$23.2M
Actual
$26.3M13.3%
- LPCNLipocine$18.6MReported
LPCNQ4 2024
Lipocine
View full reportEPS
Estimated
-$0.38
Actual
$0.00100.4%
Revenue
Estimated
$200.0K
Actual
$11.2M5499.1%
- GMEGameStop$9.7BReported
GMEQ4 2024
GameStop
View full reportEPS
Estimated
$0.08
Actual
$0.29253.7%
Revenue
Estimated
$1.5B
Actual
$1.3B15.0%
- WORWorthington$2.8BReported
WORQ3 2025
Worthington
View full reportEPS
Estimated
$0.68
Actual
$0.7916.0%
Revenue
Estimated
$291.7M
Actual
$304.5M4.4%
- ELVNEnliven Therapeutics$2.5BReported
ELVNQ4 2024
Enliven Therapeutics
View full reportEPS
Estimated
-$0.52
Actual
-$0.4611.5%
Revenue
Estimated
—
Actual
$0.00
- CRVSCorvus Pharmaceuticals$1.1BReported
CRVSQ4 2024
Corvus Pharmaceuticals
View full reportEPS
Estimated
-$0.12
Actual
$0.18250.0%
Revenue
Estimated
$0.00
Actual
$0.00
- PAYSPaysign$402MReported
PAYSQ4 2024
Paysign
View full reportEPS
Estimated
$0.03
Actual
$0.12295.7%
Revenue
Estimated
$15.2M
Actual
$58.4M284.8%
- GCTSGCT$310MReported
GCTSQ4 2024
GCT
View full reportEPS
Estimated
-$0.15
Actual
-$0.1127.9%
Revenue
Estimated
$2.1M
Actual
$1.8M13.1%
- ANTXAN2 Therapeutics$161MReported
ANTXQ4 2024
AN2 Therapeutics
View full reportEPS
Estimated
-$0.26
Actual
-$0.253.8%
Revenue
Estimated
—
Actual
$0.00
- IGMSIGM Biosciences$78.7MReported
IGMSQ4 2024
IGM Biosciences
View full reportEPS
Estimated
-$0.79
Actual
-$3.24310.1%
Revenue
Estimated
$270.0K
Actual
$2.7M892.2%
- PRTSCarParts.com$46.8MReported
PRTSQ4 2024
CarParts.com
View full reportEPS
Estimated
-$0.19
Actual
-$0.2738.6%
Revenue
Estimated
$143.6M
Actual
$133.5M7.1%
- PRPLPurple$45.3MReported
PRPLQ4 2024
Purple
View full reportEPS
Estimated
-$0.08
Actual
-$0.0712.5%
Revenue
Estimated
$130.6M
Actual
$129.0M1.2%
- GBIOGeneration Bio$37.7MReported
GBIOQ4 2024
Generation Bio
View full reportEPS
Estimated
-$0.23
Actual
-$0.3239.1%
Revenue
Estimated
$2.9M
Actual
$4.2M43.4%
- SURGSurgepays$14.2MReported
SURGQ4 2024
Surgepays
View full reportEPS
Estimated
-$0.23
Actual
-$1.01347.9%
Revenue
Estimated
$8.3M
Actual
$9.6M16.1%
- PONYPony AI Inc$3.5BReported
PONYQ4 2025
Pony AI Inc
View full reportEPS
Estimated
—
Actual
-$0.12
Revenue
Estimated
—
Actual
$14.0M
- CTASCintas$69.2BReported
CTASQ3 2025
Cintas
View full reportEPS
Estimated
$1.04
Actual
$1.138.2%
Revenue
Estimated
$2.6B
Actual
$2.6B1.4%
- PAYXPaychex$34.2BReported
PAYXQ3 2025
Paychex
View full reportEPS
Estimated
$1.44
Actual
$1.430.9%
Revenue
Estimated
$1.4B
Actual
$1.5B4.5%
- DLTRDollar Tree$22.0BReported
DLTRQ4 2024
Dollar Tree
View full reportEPS
Estimated
$2.47
Actual
$2.563.8%
Revenue
Estimated
$8.4B
Actual
$5.0B40.6%
- CHWYChewy$8.7BReported
CHWYQ4 2024
Chewy
View full reportEPS
Estimated
$0.20
Actual
$0.0575.3%
Revenue
Estimated
$3.0B
Actual
$3.2B8.2%
- THTarget Hospitality$1.7BReported
THQ4 2024
Target Hospitality
View full reportEPS
Estimated
$0.08
Actual
$0.70767.1%
Revenue
Estimated
$81.7M
Actual
$386.3M372.8%
- REXREX American$1.6BReported
REXQ4 2026
REX American
View full reportEPS
Estimated
$0.38
Actual
$3.30772.1%
Revenue
Estimated
$154.1M
Actual
$642.5M316.9%
- JKSJinkoSolar$1.1BReported
JKSQ4 2024
JinkoSolar
View full reportEPS
Estimated
-$0.01
Actual
-$1.0210361.5%
Revenue
Estimated
$3.5B
Actual
$12.6B258.1%
- CANCanaan$289MReported
CANQ4 2024
Canaan
View full reportEPS
Estimated
-$0.11
Actual
-$0.33192.7%
Revenue
Estimated
$79.3M
Actual
$88.8M11.9%
- DTILPrecision BioSciences$179MReported
DTILQ4 2024
Precision BioSciences
View full reportEPS
Estimated
-$2.93
Actual
-$2.2224.2%
Revenue
Estimated
$4.2M
Actual
$638.0K84.8%
- CYPHLeap Therapeutics$119MReported
CYPHQ4 2024
Leap Therapeutics
View full reportEPS
Estimated
-$0.38
Actual
-$0.372.6%
Revenue
Estimated
$0.00
Actual
$0.00
- ALURAllurion$10.3MReported
ALURQ4 2024
Allurion
View full reportEPS
Estimated
-$6.15
Actual
-$7.9529.3%
Revenue
Estimated
$5.5M
Actual
$5.6M2.6%
- JEFJefferies$10.7BReported
JEFQ1 2025
Jefferies
View full reportEPS
Estimated
$1.14
Actual
$0.5750.2%
Revenue
Estimated
$2.0B
Actual
$2.5B26.7%
- FULH.B. Fuller$3.5BReported
FULQ1 2025
H.B. Fuller
View full reportEPS
Estimated
$0.63
Actual
$0.2461.9%
Revenue
Estimated
-$24.0M
Actual
$788.7M3385.4%
- SCSSteelcase$1.9BReported
SCSQ4 2025
Steelcase
View full reportEPS
Estimated
$0.20
Actual
$0.2312.3%
Revenue
Estimated
$775.1M
Actual
$788.0M1.7%
- CNXCConcentrix$1.6BReported
CNXCQ1 2025
Concentrix
View full reportEPS
Estimated
$2.57
Actual
$1.0459.5%
Revenue
Estimated
$2.4B
Actual
$2.4B0.2%
- VRNTVerint$1.2BReported
VRNTQ4 2025
Verint
View full reportEPS
Estimated
$1.24
Actual
$0.4563.8%
Revenue
Estimated
$274.1M
Actual
$253.5M7.5%
- MLKNMillerKnoll$1.1BReported
MLKNQ3 2025
MillerKnoll
View full reportEPS
Estimated
$0.44
Actual
-$0.19142.8%
Revenue
Estimated
$917.8M
Actual
$876.2M4.5%
- WOOFPetco$862MReported
WOOFQ4 2024
Petco
View full reportEPS
Estimated
$0.01
Actual
-$0.05601.2%
Revenue
Estimated
$1.5B
Actual
$1.6B3.9%
- DDD3D Systems$514MReported
DDDQ4 2024
3D Systems
View full reportEPS
Estimated
-$0.11
Actual
-$0.1972.4%
Revenue
Estimated
$112.7M
Actual
$440.0M290.6%
- ARTNAArtesian$336MReported
ARTNAQ4 2024
Artesian
View full reportEPS
Estimated
$0.32
Actual
$1.98518.8%
Revenue
Estimated
$25.0M
Actual
$108.0M332.0%
- MVISMicroVision$211MReported
MVISQ4 2024
MicroVision
View full reportEPS
Estimated
-$0.08
Actual
-$0.1470.7%
Revenue
Estimated
$2.1M
Actual
$1.7M20.6%
- DERMJourney Medical$171MReported
DERMQ4 2024
Journey Medical
View full reportEPS
Estimated
-$0.15
Actual
-$0.72368.3%
Revenue
Estimated
$14.5M
Actual
$56.1M287.1%
- ZEPPZEPP Health$72.0MReported
ZEPPQ4 2024
ZEPP Health
View full reportEPS
Estimated
$0.00
Actual
-$0.09
Revenue
Estimated
$33.5M
Actual
$99.7M197.6%
- SNXTD Synnex$19.8BReported
SNXQ1 2025
TD Synnex
View full reportEPS
Estimated
$2.94
Actual
$1.9832.7%
Revenue
Estimated
$14.8B
Actual
$14.5B1.6%
- ESNTEssent$5.4BReported
ESNTQ4 2024
Essent
View full reportEPS
Estimated
$1.65
Actual
$1.584.2%
Revenue
Estimated
$308.0M
Actual
$315.0M2.3%
- TENTsakos$1.1BReported
TENQ4 2024
Tsakos
View full reportEPS
Estimated
$0.61
Actual
$0.4231.2%
Revenue
Estimated
$159.3M
Actual
$188.3M18.2%
- ABUSArbutus$909MReported
ABUSQ4 2024
Arbutus
View full reportEPS
Estimated
-$0.12
Actual
-$0.0741.9%
Revenue
Estimated
$2.3M
Actual
$1.6M30.4%
- WGOWinnebago$857MReported
WGOQ2 2025
Winnebago
View full reportEPS
Estimated
$0.19
Actual
-$0.02110.7%
Revenue
Estimated
$611.2M
Actual
$620.2M1.5%
- ABOSAcumen$183MReported
ABOSQ4 2024
Acumen
View full reportEPS
Estimated
-$0.39
Actual
-$0.6259.0%
Revenue
Estimated
$0.00
Actual
$0.00
- ATRAAtara$101MReported
ATRAQ4 2024
Atara
View full reportEPS
Estimated
-$2.48
Actual
-$1.1952.0%
Revenue
Estimated
$24.8M
Actual
$32.8M32.3%
- PDSBPDS Biotechnology$59.7MReported
PDSBQ4 2024
PDS Biotechnology
View full reportEPS
Estimated
-$0.30
Actual
-$1.03243.3%
Revenue
Estimated
—
Actual
$0.00
- SACHSachem Capital$57.1MReported
SACHQ4 2024
Sachem Capital
View full reportEPS
Estimated
-$0.45
Actual
-$0.93105.3%
Revenue
Estimated
$14.8M
Actual
$57.5M289.0%
- BTAIBioxcel Therapeutics$38.9MReported
BTAIQ4 2024
Bioxcel Therapeutics
View full reportEPS
Estimated
-$4.84
Actual
-$3.5726.2%
Revenue
Estimated
$422.1K
Actual
$366.0K13.3%
- UONEUrban One$28.1MReported
UONEQ4 2024
Urban One
View full reportEPS
Estimated
—
Actual
-$0.78
Revenue
Estimated
$110.4M
Actual
$117.1M6.1%
- LULULululemon$15.0BReported
LULUQ4 2024
Lululemon
View full reportEPS
Estimated
$5.35
Actual
$5.016.3%
Revenue
Estimated
$3.3B
Actual
$3.6B8.7%
- AGXArgan$9.5BReported
AGXQ4 2025
Argan
View full reportEPS
Estimated
$1.08
Actual
$2.22105.1%
Revenue
Estimated
$208.1M
Actual
$232.5M11.7%
- AIRAAR Corp$4.6BReported
AIRQ3 2025
AAR Corp
View full reportEPS
Estimated
$0.96
Actual
-$0.25125.9%
Revenue
Estimated
$693.5M
Actual
$678.2M2.2%
- RHRH$2.8BReported
RHQ4 2024
RH
View full reportEPS
Estimated
$1.96
Actual
$1.5819.3%
Revenue
Estimated
$812.9M
Actual
$3.6B341.7%
- BRZEBraze$2.6BReported
BRZEQ4 2025
Braze
View full reportEPS
Estimated
$0.05
Actual
-$0.17445.3%
Revenue
Estimated
$156.2M
Actual
$160.4M2.7%
- KODKodiak Sciences$2.3BReported
KODQ4 2024
Kodiak Sciences
View full reportEPS
Estimated
-$0.86
Actual
-$0.842.3%
Revenue
Estimated
—
Actual
$0.00
- TYRATyra Biosciences$1.9BReported
TYRAQ4 2024
Tyra Biosciences
View full reportEPS
Estimated
-$0.46
Actual
-$0.436.5%
Revenue
Estimated
—
Actual
$0.00
- PLSEPulse Biosciences$1.7BReported
PLSEQ4 2024
Pulse Biosciences
View full reportEPS
Estimated
—
Actual
-$0.31
Revenue
Estimated
—
Actual
$0.00
- SVRASavara$1.0BReported
SVRAQ4 2024
Savara
View full reportEPS
Estimated
-$0.11
Actual
-$0.1318.2%
Revenue
Estimated
$0.00
Actual
$0.00
- OXMOxford$700MReported
OXMQ4 2024
Oxford
View full reportEPS
Estimated
$1.64
Actual
$1.1330.9%
Revenue
Estimated
$355.4M
Actual
$391.0M10.0%
- GEVOGevo$462MReported
GEVOQ4 2024
Gevo
View full reportEPS
Estimated
-$0.09
Actual
-$0.088.8%
Revenue
Estimated
$3.8M
Actual
$8.9M135.9%
- STTKShattuck Labs$458MReported
STTKQ4 2024
Shattuck Labs
View full reportEPS
Estimated
-$0.32
Actual
-$0.3716.4%
Revenue
Estimated
$979.3K
Actual
$0.00100.0%
- IZEAIZEA$65.0MReported
IZEAQ4 2024
IZEA
View full reportEPS
Estimated
-$0.08
Actual
-$0.27237.5%
Revenue
Estimated
$13.0M
Actual
$11.0M15.4%
- SCYXScynexis$58.4MReported
SCYXQ4 2024
Scynexis
View full reportEPS
Estimated
-$0.06
Actual
-$0.44633.3%
Revenue
Estimated
$7.6M
Actual
$3.7M51.0%
- HUMAHumacyte$284MReported
HUMAQ4 2024
Humacyte
View full reportEPS
Estimated
-$0.25
Actual
-$0.1636.9%
Revenue
Estimated
$411.6K
Actual
$0.00100.0%
- SYSo-Young$165MReported
SYQ4 2024
So-Young
View full reportEPS
Estimated
$0.00
Actual
-$0.09
Revenue
Estimated
$183.0M
Actual
$1.5B701.5%
- DAVAEndava$137MReported
DAVAH12025
Endava
View full reportEPS
Estimated
$0.28
Actual
$0.1546.4%
Revenue
Estimated
$195.1M
Actual
$390.6M100.2%
- CRISCuris$20.4MReported
CRISQ4 2024
Curis
View full reportEPS
Estimated
-$1.36
Actual
-$1.258.1%
Revenue
Estimated
$2.7M
Actual
$2.4M11.5%
- STROSutro$491MReported
STROQ4 2024
Sutro
View full reportEPS
Estimated
-$0.95
Actual
-$2.96211.6%
Revenue
Estimated
$12.2M
Actual
$62.0M409.4%
- BRTBRT$275MReported
BRTQ4 2024
BRT
View full reportEPS
Estimated
-$0.12
Actual
-$0.118.3%
Revenue
Estimated
$24.7M
Actual
$24.0M3.1%
- HLVXHilleVax$105MReported
HLVXQ4 2024
HilleVax
View full reportEPS
Estimated
-$0.37
Actual
-$0.6883.8%
Revenue
Estimated
—
Actual
$0.00
- XOSXOS Inc$27.8MReported
XOSQ4 2024
XOS Inc
View full reportEPS
Estimated
-$1.24
Actual
-$2.3690.5%
Revenue
Estimated
$20.9M
Actual
$11.5M45.1%
- BOXLBoxlight$3.6MReported
BOXLQ4 2024
Boxlight
View full reportEPS
Estimated
-$2.75
Actual
-$8.65214.5%
Revenue
Estimated
$32.1M
Actual
$24.0M25.2%
- KRROKorro Bio$193MReported
KRROQ4 2024
Korro Bio
View full reportEPS
Estimated
-$2.51
Actual
-$9.37273.3%
Revenue
Estimated
—
Actual
$2.3M